• support@madhedgefundtrader.com
  • Member Login
Mad Hedge Fund Trader
  • Home
  • About
  • Store
  • Luncheons
  • Testimonials
  • Contact Us
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
Mad Hedge Fund Trader

Tesla Special Report: From Here to the Future

Diary, Newsletter

OK, let me take my victory lap.

Since I sent out this report two months ago, Tesla shares have exploded upward by a breathtaking 32,4% to $253, a new 2023 high.

And the best is yet to come!

Of course, we got an assist from several fronts. The Tesla Model Y became the world’s top-selling car in Q1, just edging out the Toyota Corolla. Then both Ford (F) and General Motors (GM) signed on to use Tesla’s national supercharger network, giving it an effective monopoly.

When I heard that the February 28 Tesla Investors Day in Austin, TX was boring, I was highly suspicious. I thought that might be a journalist’s snap judgment with a strong background in creative writing.

Engineers and scientists might have a different take, I thought. So, I listened to the entire 3 ½ hours and copied all the important charts.

What I heard was nothing less than earth-shaking, groundbreaking, and revolutionary, and won’t cost more than we would spend otherwise. All we have to do is spend more intelligently.

Elon Musk unveiled his Master Plan 3 and unleashed a cornucopia of new data which only an immense amount of research can produce. This will require all forms of transportation to be electric-powered within 20 years, except for interplanetary rockets.

As anyone who has been through an advanced physics course can tell you that internal combustion engines are woefully inefficient, converting only 25% of their energy into forward motion, and 20% if you include materials energy costs. But that was the best the 19th century could do and it worked for 151 years (Nicolaus Otto built the first gasoline-powered internal combustion engine in Germany in 1872).

Electric motors in Teslas operate closer to a 50% efficiency rating, cutting energy demand by half right there.

To move the world to an all-electric economy will cost about $10 trillion, or about 10% of world GDP. Average that out at 0.5% per year and it will take about 20 years. Adding up car and storage batteries, that means 24 terawatts worth of batteries will need to be manufactured. There are one trillion watts per terawatt.

By comparison, the sun produces 1 gigawatt of energy per square kilometer per day, or 509,600 terawatts. That means an all-electric economy dependent on batteries equivalent to less than 0.1% of the sun’s daily output. In other words, it’s miniscule.

In fact, the world is already decarbonizing far faster than people realize.

There are currently 2 billion cars and trucks in the world, 85 million a year are manufactured, and some 16 million in the US. Global EV production came to 10.6 million vehicles in 2022, an increase of 22%.

Some 60% of new electricity generation installed last year came from alternatives. That’s because in terms of power output alternatives are 40% cheaper than oil, coal, or natural gas. That’s being generous as it does not include the health care costs of carbon-based energy, which make several hundred thousand people per year ill in the US alone (asthma, lung cancer, etc.).

This means that a heck of a lot of lithium is going to be needed. Soft, white lithium is number three on the period table (you’re talking to a chemist here), is a great oxidizer, and is anything but rare. What IS rare is the lack of environmental controls and cheap labor.

This is why the bulk of lithium is produced by China and South America where it literally sits on the surface. This is all easily scalable to meet future demand. In fact, moving to an alternative-based world uses far less mining than the existing conventional one.

The shortage is not in lithium supply but in lithium processing. The world’s largest lithium consumer should know. Musk recently announced they would move into lithium processing.

Home heating is another challenge. Existing heat pumps, which I have, do a great job heating in winter and cooling in summer in southern and western states where the weather is mild. These use only one third of the energy used to heat homes with oil and natural gas.  States facing subzero temperatures are another story. This problem can be solved with a fundamental redesign of the heat pump hardware.

Here was a big surprise for me. EV’s are not going to create an exponential demand for lithium. Once you get up to a total installed base of 40 million batteries, recycling becomes the primary sources of lithium as batteries age out. They can then be reprocessed into new batteries. This eventually caps lithium demand. Future cars will use far less silicon carbide, further reducing its demand by 75%, saving $1,000 a car.

Musk is dumping the traditional 12-volt lead acid battery all Teslas have now which accounts for 87% of all start failures. Instead, he is adding a second small lithium ion one and redesigning the electrics to take 48 volts. This means lighter weight cables can handle more power at less cost. Musk hope to force the entire auto industry to move to a 48-volt standard, which should have been done decades ago.

The world’s 4 million Teslas now drive 123 million miles a day and represent the largest AI neural network on the planet. If a car in Florida makes a left turn, all the cars in the rest of the country learn from that experience.

Tesla now has 80,000 chargers in the US, including 40,000 superchargers, which can charge up 450 miles per hour and give you a full charge in 40 minutes. Tesla charged cars with 7 terawatts of power in 2022 and per kilowatt costs have dropped by 40%, with charge times down 30%. Tesla is well on its way to becoming the largest electric power utility in the United States.

Tesla’s current manufacturing capacity is 2 million cars a year across four factories (Fremont, CA, Austin, TX, Berlin, Germany, and Shanghai, China). While it took Tesla 12 years to make its first million vehicles, the 4th million took only seven months. As of today, it is cheaper to own a Tesla than the world’s biggest selling car, the Toyota Corolla, given their total lifetime costs. Work out the cost of charging a Tesla and you are paying the equivalent of 25 cents a gallon for gasoline unless you are at my house, in which case it is free.

The Gigafactory in Sparks, NV, which mass produces lithium-ion battery packs, is currently being doubled in size. In Texas, Tesla is buying wind power from the grid and offering Tesla owners a flat rate for charging of $30 a month because the cost is so low.

There are great hopes for the Cybertruck, for which Tesla has 1.5 million orders, myself included. The final price for the three-motor version will be about $100,000, the same as for a model X. The Cybertruck will have a brand new third-generation platform on which all future Tesla models will be based. It will also include the 48-volt electrical design.

Tesla’s price cuts have been wildly successful, allowing it to gain market share at its competitors' expense. Tesla is really just passing on the recent collapse in commodity prices. So far in 2023, Lithium prices have fallen by 20% and copper by 15%. Tesla prices will continue to fall, especially when the new $25,000 Model 2 is brought to market in 2024. That will really decimate the competition.

Tesla has also taken the plunge into the insurance industry, charging drivers on their actual driving history, which they already collect. If you drive like a little old lady, it can run as little as $180 a month. If you drive like Mad Max, it’s more, but not as much as a conventional car insurance company.

Rates change monthly depending on your driving record. Parked in a garage gives you a perfect score of 90 and it drops from there. It’s all about reducing the total cost of a Tesla car. Not such a bad deal if you let their computer do all the driving.

What will Tesla disrupt next?

All in all, it was a breathtaking presentation, which Elon delivered coolly and calmly. It is with the greatest enthusiasm that I reiterate my $1,000 per share price target.

To watch the Tesla Investor Day in its entirety on YouTube, please click here.

John Thomas
CEO & Publisher
The Diary of a Mad Hedge Fund Trader

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2023-06-14 09:02:232023-06-14 14:15:59Tesla Special Report: From Here to the Future
Mad Hedge Fund Trader

June 13, 2023

Biotech Letter

Mad Hedge Biotech and Healthcare Letter
June 13, 2023
Fiat Lux

Featured Trade:

(BUCKING THE TREND)
(VRTX), (ABBV), (CRSP)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2023-06-13 15:02:522023-06-14 14:41:14June 13, 2023
Mad Hedge Fund Trader

Bucking the Trend

Biotech Letter

The notion of "Sell in May and go away" hasn't exactly proven true this year in 2023. Surprisingly, the stock market has been experiencing an impressive upward trend, especially in June, and there may still be further potential for growth.

Allow me to share one of my favorite examples that embody both profitability and consistent expansion, all while enjoying a significant competitive edge.

In the biotechnology and healthcare sector, Vertex Pharmaceuticals (VRTX 1.94%) fits the description perfectly.

This company stands out as the undisputed leader in the market for cystic fibrosis treatments, offering a unique portfolio of drugs that specifically target the underlying cause of this genetic condition.

These groundbreaking medications, known as CFTR modulators, have successfully been introduced to the market, with Vertex Pharmaceuticals spearheading the way by bringing forth four of them.

Vertex has been continuously making remarkable progress in the field of cystic fibrosis (CF) treatment.

A notable achievement is the expanded approval of their drug, Kalydeco, by the U.S. Food and Drug Administration. It can now be used to treat CF patients as young as one-month-old, marking a groundbreaking milestone as the first CFTR modulator ever approved for this age group.

Kalydeco has also been a significant revenue generator for Vertex, ranking as their second highest-earning drug with an impressive $553 million generated over 12 months.

But there's more to Vertex's success.

Their flagship medication, Trikafta, takes the lead as their best-selling drug, raking in a staggering $7.7 billion in revenue in 2022 alone.

Recently, Trikafta received approval to treat children as young as two years old with specific mutations, providing relief to nearly 1,000 more individuals in the cystic fibrosis patient community.

The long-lasting patent protection of Trikafta, with approximately 14 years remaining before expiration, holds great significance for Vertex Pharmaceuticals. With a relatively modest patient population of 88,000, the company has ample opportunities for further growth.

The robust revenue and profits of Vertex's CF franchise speak to their success in this area. Additionally, AbbVie's (ABBV) decision to discontinue its CF program further solidifies Vertex's monopoly in the cystic fibrosis field, strengthening its position for continued success.

While capitalizing on the expanding market for cystic fibrosis treatments, Vertex Pharmaceuticals also targets underserved areas to drive long-term growth.

One promising drug candidate in their pipeline is VX-548, a non-opioid medication designed to address acute pain conditions, which is nearing commercialization.

Moreover, Vertex has a highly promising candidate in its pipeline that goes beyond cystic fibrosis.

Collaborating with CRISPR Therapeutics (CRSP), the company eagerly awaits regulatory approvals for exa-cel, an innovative treatment for sickle cell disease and transfusion-dependent beta-thalassemia, in both the United States and Europe.

Exa-cel represents just the tip of the iceberg when it comes to Vertex's upcoming arsenal of new drugs.

The company holds great optimism for VX-548, a cutting-edge non-opioid therapy targeting acute pain, as well as its triple-drug combination for cystic fibrosis, which features vanzacaftor.

Both treatments are undergoing Phase III trials, with expectations for completion in late 2023 or early 2024.

Additionally, Vertex is conducting a pivotal trial for inaxaplin, a potential treatment for APOL1-mediated kidney disease that impacts a larger patient population than cystic fibrosis.

Needless to say, Vertex has been experiencing an exceptional streak, consistently outperforming the market over the past year. The best part is that its potential to generate significant returns extends well into the next decade.

While Vertex possesses a variety of potential approvals for treating cystic fibrosis, some of which may materialize before 2028, its CF-related revenue is expected to grow substantially even without factoring in those additional approvals.

Analysts anticipate a solid annual increase of 8.2% in the company's overall revenue over the next five years. Although this growth rate is commendable for a biotech industry heavyweight, it falls short of Vertex's impressive 38% annual growth achieved in the previous five years.

From my perspective, the projected 8.2% growth appears rather conservative.

This sentiment is particularly amplified when considering the imminent potential approval of exa-cel, an innovative gene-editing therapy targeting sickle cell disease (SCD) and beta-thalassemia (TDT).

After all, the initial market value of exa-cel could soar to a staggering $64 billion, and given the life-altering impact it offers, a price tag of approximately $2 million per treatment is justifiable.

Honestly, I'm hard-pressed to find anything negative to say about Vertex. This prominent biotech company is constantly delivering positive news and making significant strides on all fronts. I recommend you buy the dip.

 

vertex cystic fibrosis

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2023-06-13 15:00:492023-06-28 20:28:26Bucking the Trend
Mad Hedge Fund Trader

Trade Alert - (CRM) June 13, 2023 - TAKE PROFITS - SELL

Tech Alert

When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline. Read more

https://www.madhedgefundtrader.com/wp-content/uploads/2016/02/Alert-e1457452190575.jpg 135 150 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2023-06-13 12:51:052023-06-13 12:51:05Trade Alert - (CRM) June 13, 2023 - TAKE PROFITS - SELL
Mad Hedge Fund Trader

June 13, 2023

Diary, Newsletter, Summary

Global Market Comments
June 13, 2023
Fiat Lux

Featured Trades:

(Trade Alert - (X) LEAPS – BUY)

 

CLICK HERE to download today's position sheet.

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2023-06-13 09:06:452023-06-13 11:12:14June 13, 2023
Mad Hedge Fund Trader

Trade Alert - (X) LEAPS - Buy

Diary, Newsletter

BUY the US Steel (X) December 2025 $20-$23 at-the-money vertical Bull Call spread LEAPS at $1.29 or best

Opening Trade

6-13-2023

expiration date: December 19, 2025

Number of Contracts = 1 contract

I normally don’t look at industries that are besieged by foreign competition, undercut by cheap imports, bedeviled by union problems, are major polluters, and whose principal product has declined in output by 32% since 1970, from 140 million tons a year to only 94.7 million tons.

However, I learned a lot covering the Japanese steel industry for Rupert Murdoch’s Australian newspaper for a decade during the 1970s.

In fact, I learned so much that President Jimmy Carter offered to appoint me as Deputy US Secretary of the Treasury for International Affairs so I could negotiate a steel pact with Japan. I turned the job down because as a G-15 I would only earn $15,000 a year.

Did I also mention that I was a dummy in the 1970s?

Walking in and out of steel mills all over the world for a decade there is one thing I learned for sure. There is no better call on the global economy.

US Steel (X) is the largest steel producer in the United States. In 2022, (X) knocked out 22.4 million tons of steel. Over the last 53 years, it has dealt with the onslaught of competition from Japan and China by becoming the most efficient blast furnace steel producer in the world.

As a result, (X) is highly leveraged to any increase in global steel demand. Its principal customers are the auto, construction, housing, shipbuilding, and oil industries.

(X) is in the half of the stock market that is currently discounting a deep recession. If we get one, the current share price is justified. If we don’t, the shares are overdue for a nice run-up. That makes (X) an ideal LEAPS candidate.

To learn more about US Steel, please visit their website at https://www.ussteel.com

I am therefore buying the US Steel (X) December 2025 $20-$23 at-the-money vertical Bull Call spread LEAPS at $1.29 or best.

Don’t pay more than $2.00 or you’ll be chasing on a risk/reward basis.

If you are looking for a cheap lottery ticket, then here is a lottery ticket.

While the chance of winning a real lottery is something like a million to one, this one is more like 10:1 in your favor. And the payoff is more than 2:1. That is the probability that US Steel (X) shares will rise over the next 32 months.

If you want to get more aggressive with more leverage, use a pair of strike prices higher up. This will give you a larger number of contracts at a lower price.

Please note that these options are illiquid, and it may take some work to get in or out. Start at my price and work your way up until you get done. Executing these trades is more an art than a science.

Let’s say the US Steel (X) December 2025 $20-$23 at-the-money vertical Bull Call spread LEAPS are showing a bid/offer spread of $1.25-$2.00. Enter an order for one contract at $1.30, another for $1.40, another for $1.50, and so on. Eventually, you will enter a price that gets filled immediately. That is the real price. Then enter an order for your full position at that real price.

Notice that the day-to-day volatility of LEAPS prices is miniscule since the time value is so great. This means that the day-to-day moves in your P&L will be small. It also means you can buy your position over the course of a month just entering new orders every day. I know this can be tedious, but getting screwed by overpaying for a position is even more tedious.

Look at the math below and you will see that if (X) shares are slightly higher than unchanged in 32 months it will generate a 132.6% profit with this position, such is the wonder of LEAPS.

Only use a limit order. DO NOT USE MARKET ORDERS UNDER ANY CIRCUMSTANCES. Just enter a limit order and work it until you find the real price.

This is a bet that US Steel will close above $23 by the December 19, 2025 options expiration in 32 months.

Here are the specific trades you need to execute this position:

Buy 1 December 2025 (X) $20 call at……..…….………$9.00
Sell short 1 December 2025 (X) $23 call at……….……$7.71
Net Cost:………………...........………….………..…….….....$1.29

Potential Profit: $3.00 - $1.29 = $1.71

(1 X 100 X $1.71) = $171 or 100% 32 months.

 

 

 

To see how to enter this trade in your online platform, please look at the order ticket below, which I pulled off of Interactive Brokers.

If you are uncertain on how to execute an options spread, please watch my training video on “How to Execute a Vertical Bull Call Debit Spread” by clicking here.

The best execution can be had by placing your bid for the entire spread in the middle market and waiting for the market to come to you. The difference between the bid and the offer on these deep in-the-money spread trades can be enormous.

Don’t execute the legs individually or you will end up losing much of your profit. Spread pricing can be very volatile on expiration months farther out.

 

 

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2023-06-13 09:02:502023-06-13 11:11:07Trade Alert - (X) LEAPS - Buy
Mad Hedge Fund Trader

June 12, 2023

Tech Letter

Mad Hedge Technology Letter
June 12, 2023
Fiat Lux

Featured Trade:

(GREEDFLATION WINS OUT)
($COMPQ), (UBER)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2023-06-12 19:04:342023-06-12 19:16:34June 12, 2023
Mad Hedge Fund Trader

Greedflation Wins Out

Tech Letter

Tech companies are doing well and so is the overall stock market.

It doesn’t make sense to listen to all the doomsday personalities going on national TV to scare us out of making money.

Just zone them out – they are useless.

Back in the real world, the excellent performance is great news for holders of US tech stocks who have been carrying the load in 2023.

The tech-based Nasdaq index ($COMPQ) has returned 27% YTD and anyone betting on an “earnings recession” has had their head handed to them.

Mr. Market has continued to look through any risk presented and shrugging it off like it doesn’t matter.

We have been waiting for that recession which hasn’t arrived for almost 3 years now.

People will have to continue to wait too as the job numbers have been excellent.

Instead, we should focus on why tech companies are doing so well and what makes their balance sheets tick.

In a widespread industry survey, 89% of respondents said US companies have been raising prices in excess of their own costs since the pandemic began in 2020. Almost four out of five said that tight monetary policy is the right way to tackle profit-led inflation.

The surge in corporate markups cannot be understated and tech companies have done exceptionally well with Uber (UBER) rides more costly as just one little example among many.

Margins soared in the initial pandemic years, and have defied convention by remaining historically high since then.

The unique circumstances of the pandemic – severe supply constraints, followed by an unprecedented burst of stimulus-fueled demand – lie behind the widening of profit margins, which hit 70-year highs in the US.

Even if margins come down a little because customers start to balk at high prices, the price reductions will be most likely incremental.

Standard economic theory holds that profit margins are “mean-reverting’’ – in other words, they tend to be pulled back to normal levels. It’s supposed to work like this: An industry with high profits should attract new entrants, with increased competition forcing margins lower.

However, many tech companies are operating as de-facto monopolies in their subsector and possess an unprecedented amount of pricing power for the products they sell.

This has led to the idea more colloquially known as “greedflation.’’

Until a rising backlash against monopolies or oligopolies triggers buyer protests, the tech playbook should be to buy those companies that look most similar to monopolies.

Ultimately “greedflation’’ is great for holders of tech stocks and not necessarily good for US consumers.

Clearly, there is a profit honeymoon with the likes of big tech raking in the dough.

They can even push out aggressive and abstract products like the Apple VR headset for $3,500 per clip.

That’s not a defensive strategy as well as absorbing billions to develop the product.

Coupled with the lust for anything generative AI, the conflation with higher margins has triggered a momentous rally in tech stocks.

As we narrow down our paths for the rest of the year, a demonstrative easing cycle is setting up promising to catapult tech stocks another leg up from current levels.

The considers that inflation is dropping fast from 5% to 4% and projections could find us in the 3%-ish range in the next month or two which is a strong tailwind for tech stocks.

It’s hard to see where the sellers come in and I would continue to buy every small dip in every quality tech stock name.

 

us tech stocks

 

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2023-06-12 19:02:462023-06-28 20:53:27Greedflation Wins Out
Mad Hedge Fund Trader

Quote of the Day - June 12, 2023

Tech Letter

“Take risks now. Do something bold. You won’t regret it.” – Said CEO of Tesla Elon Musk

 

https://www.madhedgefundtrader.com/wp-content/uploads/2022/12/elon-musk-e1696019090338.png 372 380 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2023-06-12 19:00:192023-06-12 19:16:03Quote of the Day - June 12, 2023
Mad Hedge Fund Trader

June 12, 2023

Jacque's Post

 

(SUMMARY OF JUNE 7, 2023, MAD HEDGE WEBINAR)

June 12, 2023

Hello everyone,

Hope you had a wonderful weekend.

Welcome to a new week.

Title: The Next Rotation is Here

The Mad Hedge Traders and Investors Summit. Don’t forget to register.

Lunches

July 6 New York
July 13 Seminar at Sea
July 19 London

Trade Alert Performance

June 0.01%
2023 year to date +61.74%
+658.93% since inception
40 out of 44 trade alerts profitable.

Trading opportunities very few.

Positions

TSLA 6/120-130 call spread 10%
FCX 6/32-35 call spread 10%

20% long
80% cash
VIX – at $13.

 

Method to My Madness – A Bipolar Market

Equity allocations are at a 15 year low with massive amounts of cash in 90-day T-bills.

Expect funds to pour into stocks in the second half of the year as per the Mad Hedge play book.

Big rotation out of cash into Industrials, commodities and energy is near.

Bonds weaken – looking for another 0.25% rise June 14th.

Summer will present the best buying opportunity of the year. Precious metals and commodities should be at the top of your list.

Global Economy

Non-farm payroll soars by 339,000 in May for the 10th consecutive month of increases.

Unemployment jumped 0.3% to 3.7%.

The biggest rise in unemployment for three years.

Inflation continues to fall 0.4% in April.

China’s PMI dives – struggling out of the post-covid world.

Stocks

They are not reflecting the massive increase in earnings and the large multiple expansion.

Record $8.5 billion poured into tech stocks last week – “the Magnificent Seven”.

Don’t forget to take profits in tech if you are a short-term trader.

Tech could move sideways before the next move up.

Rotate into commodities, industrials, and energy.

If a Black Swan decides to land on us, it could take the S&P500 down 17-20%.

“The Magnificent Seven” has made new highs for the year. (Apple, Google, Meta, Amazon, Salesforce, Nvidia, and Tesla).

 

LEAPS candidates

CAT Caterpillar
FCX Freeport McMoran
X US Steel
GS Goldman Sachs
MS Morgan Stanley

Bonds

Bonds plunge on a red-hot May non-farm payroll, which suggests another quarter point interest rate rise from the Fed at the June or July meeting.

Fitch puts US debt on credit watch. First time since 2011 Moody’s downgrades from AAA to AA+.

Treasury to issue $1 trillion in Y-bills within weeks after debt ceiling deal, pushing short-term yields up.

Keep buying 90-day T-bills now pushing a 5.2% risk-free yield.

Looking for 2.5% yield by the end of 2023.

June bond ETFs (JNK) and (HYG) are a great high-yield play.

Foreign Currencies

US$ jumps on May nonfarm payroll suggesting another ¼ point interest rate hike from the Fed at the June13-14 meeting.

Any strength in the dollar will be temporary.

Rapidly worsening economic data sparking recession fears.

10 consecutive months of inflation is another indicator of a slowdown.

Looking for new dollar lows by the end of 2023.

Buy FXE, FXB, FXY, and FXA on dips.

 

Energy and Commodities

Saudi Arabia cuts again adding another 1 million barrels a day reduction to the existing 2 million one.

The goal is to prevent a price collapse in the face of a slowing global economy.

Oil collapse is signaling a recession as is weakness in other commodities, even lithium.

Tesla becomes world’s largest selling car.

Buy (USO) on dips as an economic recovery play.

China expects LNG price spike later this year due to coming supply shortages and a recovering economy.

Precious Metals

Fear of rising interest rates causing metals to drop and bounce around a lot.

JP Morgan recommends adding cash and Gold.

Gold headed to $3000 by 2025.

Soon-to-be falling interest rates is the main driver here, and the winter season in crypto.

Silver has a higher beta and is a better play.

Russia and China are also stockpiling gold to sidestep international sanctions.

 

LEAPS candidates

GOLD Barrick Gold
GDX VanEck Vectors Gold Miners ETF
SLV iShares Silver Trust ETF
WPM Wheaton Precious Metals

 

Real Estate

30-year fixed rate mortgage jumps back to 7.0%.

Worst case, home prices go sideways from here until lower interest rates launch a new bull market in housing.

Home builder sentiment up for the 10th straight month, as it will be for the next decade.

CCI – Crown Castle International – great income play, with 5.50% yield.

Next Webinar is on June 21, 2023.

Wishing you all a week filled with adventure and wonder.

 

Cheers,

Jacquie

 

 

 

 

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2023-06-12 19:00:182023-06-12 19:37:44June 12, 2023
Page 10 of 14«‹89101112›»

tastytrade, Inc. (“tastytrade”) has entered into a Marketing Agreement with Mad Hedge Fund Trader (“Marketing Agent”) whereby tastytrade pays compensation to Marketing Agent to recommend tastytrade’s brokerage services. The existence of this Marketing Agreement should not be deemed as an endorsement or recommendation of Marketing Agent by tastytrade and/or any of its affiliated companies. Neither tastytrade nor any of its affiliated companies is responsible for the privacy practices of Marketing Agent or this website. tastytrade does not warrant the accuracy or content of the products or services offered by Marketing Agent or this website. Marketing Agent is independent and is not an affiliate of tastytrade. 

Legal Disclaimer

There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.

Copyright © 2025. Mad Hedge Fund Trader. All Rights Reserved. support@madhedgefundtrader.com
  • Privacy Policy
  • Disclaimer
  • FAQ
Scroll to top